宫颈癌患者术后旋转调强与固定野调强放疗计划的剂量学比较

doi:10.13481/j.1671-587x.20150435

吉林大学学报(医学版) ›› 2015, Vol. 41 ›› Issue (04): 850-853.doi: 10.13481/j.1671-587x.20150435

宫颈癌患者术后旋转调强与固定野调强放疗计划的剂量学比较

刘翔宇¹, 王辉东², 郭明芳³, 谢悦⁴

1. 重庆市肿瘤研究所资产设备部, 重庆 400030;
2. 吉林大学第一医院放疗科, 吉林长春 130021;
3. 重庆市肿瘤研究所妇瘤科, 重庆 400030;
4. 重庆市肿瘤研究所放疗科, 重庆 400030

收稿日期:2014-09-18 发布日期:2015-08-01
通讯作者: 谢悦,主治医师,医学硕士(Tel:023-65309274,E-mail:344899525@qq.com) E-mail:344899525@qq.com
作者简介:刘翔宇(1978-),男,四川省绵阳市人,高级工程师,主要从事放射物理学方面的研究。
基金资助:
重庆市卫生计生委医学科研计划项目资助课题(20140293)

Comparison of dosiology between intensity-modulated arc therapy plan and fixed field IMRT plan in patients with cervical cancer after operation

LIU Xiangyu¹, WANG Huidong², GUO Mingfang³, XIE Yue⁴

1. Department of Equipment, Chongqing Cancer Institute and Hospital, Chongqing 400030, China;
2. Department of Radiotherapy, First Hospital, Jilin University, Changchun 130021, China;
3. Department of GynecologyTumor, Chongqing Cancer Institute and Hospital, Chongqing 400030, China;
4. Department of Radiation Oncology, Chongqing Cancer Institute and Hospital, Chongqing 400030, China

Received:2014-09-18 Published:2015-08-01

摘要/Abstract

摘要：

目的: 探讨宫颈癌患者术后放疗旋转调强放射治疗(IMAT)和固定野调强放射治疗(IMRT)剂量学的优劣,为其临床应用提供依据。方法: 选择宫颈癌根治术后患者19例,行CT模拟定位,并勾画靶区及危及器官。在Eclipse 8.6计划系统上分别对每例患者设计IMAT和IMRT2种放疗计划,评估靶区及危及器官的剂量学差异。结果: 19例患者IMAT和IMRT放疗计划的设计时间分别为(129±3)和(30±1) min(P=0.000),在Varian IX加速器上的治疗时间分别为(3.17±0.23)和(6.55±0.17) min(P=0.009),靶区均匀指数(HI)分别为1.08±0.01和1.10±0.01(P=0.175),靶区适形指数(CI)分别为0.88±0.01和0.82±0.01(P=0.000)。IMRT计划的直肠、膀胱、小肠和股骨颈等危及器官受量接近或略小于IMAT。结论: 与IMRT相比,IMAT在靶区剂量和CI有一定的优势,HI和危及器官受量两者较为接近,IMAT计划设计耗时增加了近3倍,治疗时间减少一半。临床上在计划设计时间充裕的前提下,建议尽量设计IMAT计划。

关键词: 宫颈肿瘤, 旋转调强放射治疗, 固定野调强放射治疗

Abstract:

Objective To explore the advantages and disadvantages of the intensity modulated arc therapy(IMAT) plans and intensity modulated radiation therapy(IMRT) plan,and to provide the basis for their clinical application. Methods 19 patients with cervical cancer after operation were selected.The patients were scanned by simulation CT,and the targets and organs at risk were contoured. IMAT plan and IMRT plan were designed respectively in Eclipse 8.6 planning system.The treatment time and differences of the dose distribution in the targets and organs at risk of IMAT and IMRT plans were compared. Results The average design time of IMAT and IMRT plans of the 19 patients was (129±3) and (30±1) min(P=0.000);the average treatment time on Varian IX accelerator was (3.17±0.23) and (6.55±0.17) min(P=0.009).The homogeneity index(HI) of targets were 1.08 ± 0.01 and 1.10 ± 0.01(P=0.175).The conformal index(CI) of targets were 0.88 ± 0.01 and 0.82 ± 0.01(P=0.000).IMRT plan had the smaller doses at rectum,bladder,small intestine and neck of femoral compared with IMAT. Conclusion Compared with IMRT,IMAT plan has the advantages in dose distribution at targets and CI,its HI and doses of organs at risk are almost same with IMRT.Compared with IMRT,the design time of IMRT plan is increased three times,and the treatment time is reduced by half.In clinic,if the planning time is affluent,the IMAT plan is recommended.

Key words: cervical neoplsms, intensity modulated arc therapy, intensity modulated radiation therapy

中图分类号:

R737.33

刘翔宇, 王辉东, 郭明芳, 谢悦. 宫颈癌患者术后旋转调强与固定野调强放疗计划的剂量学比较[J]. 吉林大学学报(医学版), 2015, 41(04): 850-853.

LIU Xiangyu, WANG Huidong, GUO Mingfang, XIE Yue. Comparison of dosiology between intensity-modulated arc therapy plan and fixed field IMRT plan in patients with cervical cancer after operation[J]. Journal of Jilin University Medicine Edition, 2015, 41(04): 850-853.

参考文献

[1] 孙晓欢,周咏春,谭丽娜,等.容积旋转调强与固定野调强在宫颈癌术后放疗中的剂量学比较 [J].中国医学物理学杂志,2014,31(1):4604-4607.

[2] 蒋军,李莉,张利文,等.宫颈癌术后旋转拉弧适形和调强及三维适形放疗计划对比研究 [J].中华肿瘤防治杂志,2014,21(8):620-625.

[3] 杨国姿,潘振宇,夏文明,等.容积旋转调强与固定野动态调强在宫颈癌术后放疗的剂量学比较 [J].中华放射医学与防护杂志,2014,34(1):37-40.

[4] 李军,陈雪梅,张西志,等.宫颈癌术后常规与旋转容积调强放疗计划剂量学研究 [J].中华肿瘤防治杂志,2014,21(14):1104-1108.

[5] 冯梅,郭爱华,蔡勇君,等.宫颈癌不同根治性放疗技术剂量学研究[J].中华肿瘤防治杂志,2012,19(20):1572-1575.

[6] Cozzi L,Dinshaw KA,Shribastaba SK,et al.A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy[J].Int J Radiat Oncol Bilo Phys,2008,89(9):180-191.

[7] Mell LK,Tiryaki H,Ahn KH,et al.Dosimetric comparison of bone marrow sparing intensity modulated radiotherapy versus conventional techniques for treatmemt of cervical cancer[J].Int J Radiat Oncol Bilo Phys,2008,71(5):1504-1510.

[8] Chen MF,Tseng CJ,Tseng CC,et al.Clinical outcome in post-hysterectomy cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy:Comparison with conventional radiotherapy[J].Int J Radiat Oncol Biol Phys,2007,67(3):1438-1444.

[9] Huang B,Fang Z,Huang Y,et al.A dosimetric analysis of volumetric-modulated arc radiotherapy with jaw width restriction vs 7 field intensity-modulated radiotherapy for definitive treatment of cervical cancer [J]. Br J Radiol,2014,87(1039):20140183.

[10] Brahme A. Treatment optimization using physical and radiobiology objective functions[A].Smith AR. Radiation Therapy Physics[M].Berlin:Springer Verlog,1995:209.

[11] Yu CX.Intensity-modulated arc therapy with dynamic multi-leaf collimation:An alternative to tomotherapy[J].Phys Med Biol,1995,40(9):1435-1439.

[12] Otto K.Volumetric modulated arc therapy:IMRT in a single gantry arc[J].Med Phys,2008,35(1):310-317.

[13] 肖锋,宋晖,魏丽春,等.宫颈癌调强放疗膀胱受照剂量的评价[J].中华肿瘤防治杂志,2011,18(6):463-465.

[14] 蒋璠,吴昊,弓健,等.快速旋转调强与固定野动态调强在直肠癌术前放疗中的剂量学比较[J].中华放射医学与防护杂志,2011,31(3):322-325.

[15] 刘翔宇,柳先锋,何亚男,等.宫颈癌放疗中的快速旋转调强计划和调强计划比较[J].中华放射肿瘤学杂志,2011,31(3):326-328.

[16] Ling CC,Zhang P,Archambault Y,et al.Commissioning and quality assurance of RapidArc radiotherapy delivery system[J].Int J Radiat Oncol Bilo Phys,2008,72(6):575-581.

[17] Guckenberger M,Richter A,Krieger T,et al.Is a single arc sufficent in voumetric-modulated arc therapy for complex-shaped target volumes[J]. Radiat Oncol,2009,93(9):259-265.

宫颈癌患者术后旋转调强与固定野调强放疗计划的剂量学比较

Comparison of dosiology between intensity-modulated arc therapy plan and fixed field IMRT plan in patients with cervical cancer after operation

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	安乐, 杨建征, 胡春梅, 于琼, 肖晗, 郝书弘, 唐艳. 多囊蛋白1基因对人宫颈癌HeLa细胞的抗凋亡作用[J]. 吉林大学学报(医学版), 2018, 44(04): 776-779.
[2]	徐丽, 张巍. 樟脑磺哑嗪对人宫颈癌HeLa细胞凋亡的诱导作用及其机制[J]. 吉林大学学报(医学版), 2017, 43(06): 1161-1164.
[3]	文思敏, 于多, 吕欣, 王铁君. 紫杉醇联合顺铂与单药顺铂2种同步放化疗方案对中晚期宫颈癌患者预后的影响及安全性评价[J]. 吉林大学学报(医学版), 2017, 43(05): 1002-1008.
[4]	邓子亮, 王森, 黎鹏, 解奎龙, 李淑贤, 周世雄, 贺晓舟, 陈东, 郭洪胜. 白细胞介素37对宫颈癌HeLa细胞顺铂化疗敏感性的增强作用[J]. 吉林大学学报(医学版), 2017, 43(05): 862-866.
[5]	蒋雪园, 朴仙姬, 刘畅, 罗英花, 孙虎男, 韩英浩, 申贵男, 臧延青, 金成浩. 四溴苯三唑对宫颈癌HeLa细胞凋亡的诱导作用及其机制[J]. 吉林大学学报(医学版), 2017, 43(03): 561-565.
[6]	强欣, 霍文艳, 杨灿, 范亚楠, 石彩云, 白海花. p16INK4a蛋白在蒙古族患者宫颈病变组织中的表达及其意义[J]. 吉林大学学报(医学版), 2017, 43(02): 353-355.
[7]	孙小梅, 夏文明, 姜新, 陈祥, 李涛, 曲雅勤. 局部晚期胰腺癌容积旋转调强与五野调强放疗的剂量学比较[J]. 吉林大学学报(医学版), 2017, 43(02): 365-368.
[8]	焦园园, 张金金, 李万颖, 李思莹, 洪晓玲, 谢敏, 张松灵. 乙醛脱氢酶1在宫颈癌发生发展中作用的研究进展[J]. 吉林大学学报(医学版), 2017, 43(01): 196-199.
[9]	刘倩倩, 孙蕾, 边丽, 韩今华, 贾秀秀, 姚晓晴, 陈玉丙, 宋新灵. 宫颈癌放疗患者对医疗行为的认知差异与焦虑程度的关系[J]. 吉林大学学报(医学版), 2017, 43(01): 115-119.
[10]	徐路, 曾林川, 于洋, 窦茗瀚, 刘师兵, 李松岩, 徐冶. 钙离子在顺铂诱导宫颈癌HeLa细胞自噬反应中的作用[J]. 吉林大学学报(医学版), 2016, 42(06): 1045-1048.
[11]	周解平, 王鹏, 钱立庭, 吴爱东. 宫颈癌术后静态调强放疗与单个和2个全弧容积调强弧形治疗的剂量学比较[J]. 吉林大学学报(医学版), 2016, 42(01): 120-124.
[12]	王智亮, 余腾骅, 秦琴, 吴雨桐, 张文倩, 华媛媛, 熊正爱, 周玮. 不可逆性电穿孔介导HPV16 E6 shRNA干扰质粒对宫颈癌SiHa细胞增殖的影响[J]. 吉林大学学报(医学版), 2015, 41(06): 1107-1112.
[13]	张巍, 吴亚猛, 陈思瑶, 张琳娜, 韩景春, 那文婷, 金瑛. 胡桃醌对宫颈癌SiHa细胞增殖及细胞周期的影响[J]. 吉林大学学报(医学版), 2015, 41(04): 697-700.
[14]	张静文, 郑连文, 常笑语, 刘永正, 高利伟, 付璐璐, 徐影. 宫颈癌根治术后反射性尿闭1例报告并文献复习[J]. 吉林大学学报(医学版), 2015, 41(04): 854-857.
[15]	于慧玲, 李冬梅, 孙勤暖, 马洪喜. 不同宫颈病变患者血清和宫颈病变组织中凋亡相关因子的表达及其临床意义[J]. 吉林大学学报(医学版), 2015, 41(01): 129-134.